JBJoel Neves Briard

Joel Neves Briard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joel Neves Briard has a total of 178 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Extension of the FUNC Score for Prediction of 12-Month Functional Independence after Primary Intracerebral Hemorrhage

    by Joel Neves Briard, Vedant Kansara, Qi Shen, You Lim Song, Amy B. Cami, Angela G. Velazquez, Justin M. Esposito, Alex J. Klein, Shivani Ghoshal, Sachin Agarwal, et al.

    Background/Objective The Functional Outcome in Patients with Primary Intracerebral Hemorrhage (FUNC) score was initially validated for prediction of functional independence on the Glasgow Outcome Scale (GOS) 90 days after intracerebral hemorrhage (ICH), but recovery often extends beyond 3 months. Our objective was to extend the FUNC score for prediction of 12-month functional independence to strengthen its utility for family counseling and research methodology. Methods We conducted a single-center prospective cohort study enrolling adult patients with primary ICH between February 2009 and January 2018. We calculated FUNC scores at admission and assessed GOS 12 months after ICH. The primary outcome was 12-month functional independence, defined as a GOS score ≥ 4. We calculated the area under the receiver operating characteristic curve (AUC) of the FUNC score using logistic regression, handling missing GOS with multiple imputation by chained equations. We evaluated score calibration using a calibration curve and the Brier score, and we assessed clinical utility using decision curve analysis. Results A total of 535 patients were included [median (IQR) age 68 (54–79) years, 237 (44%) female, median (IQR) NIHSS 16 (6–25), median (IQR) FUNC 8 (6–9)]. Overall, 99 of 445 (22%) patients with known 12-month GOS achieved functional independence. The FUNC score had AUC of 0.79 (95% CI 0.75–0.84) for 12-month functional independence. The calibration plot was reasonable, with modest evidence of overestimation at low predicted probabilities, and the Brier score was 0.15. A net benefit was observed across 5–50% threshold probabilities. Conclusions The FUNC score’s predictive performance for 12-month functional independence was comparable to its originally validated 3-month discrimination. Following external validation across centers, the FUNC score may be leveraged to counsel families on global measures of long-term functional independence and to implement sliding dichotomy methodology in ICH research.

  • Surface EEG to Identify Cognitive Motor Dissociation After Acute Brain Injury

    by Satoshi Egawa, Nicole Casson, Joel Neves Briard, Qi Shen, Vedant Kansara, Itamar Niesvizky-Kogan, Elizabeth Carroll, Jerina C. Carmona, You Lim Song, Alex J. Klein, et al.

    Purpose: Cognitive motor dissociation (CMD) is associated with long-term recovery in acute brain injury, but CMD testing is only available in few centers. Our objective was to identify surface EEG patterns with high sensitivity or positive predictive value (PPV) for CMD in patients with acute disorders of consciousness to refine allocation of this resource-intensive test. Methods: In this observational cohort study, we enrolled clinically unresponsive, acutely brain injured patients who underwent continuous surface EEG and CMD assessments. CMD was detected by applying a machine learning algorithm to EEG acquired during a motor command paradigm presentation. Electroencephalographers blinded to CMD test results applied standardized ACNS criteria to the EEGs acquired during CMD assessments. We calculated accuracy measures of surface EEG findings for CMD test results using generalized estimating equations, with an exchangeable matrix and accounting for repeated measures per patient. Results: We included 185 patients (mean age: 62 ± 17; 85 [46%] female) and 282 CMD assessments. CMD testing was positive in 39 (14%) assessments. Sensitivity and PPV of normal background voltage, symmetry, and continuity were, respectively, 77% (95% CI: 60%–88%) and 19% (95% CI: 13%–26%), 74% (95% CI: 58%–86%) and 14% (95% CI: 10%–20%), and 74% (95% CI: 58%–86%) and 14% (95% CI: 9%–19%). All EEGs with burst suppression, suppression, sporadic epileptiform discharges, lateralized periodic discharges, bilateral independent periodic discharges, electrographic seizures, and brief potentially ictal rhythmic discharges had negative CMD tests. Conclusions: Surface EEG findings are not reliable to screen for CMD or to identify patterns conferring higher CMD pretest probability.

  • Open Access

    Extension of the FUNC score for prediction of 12-month functional independence after primary intracerebral hemorrhage

    by Joel Neves Briard, Vedant Kansara, Qi Shen, You Lim Song, Amy B. Cami, Angela G. Velazquez, Justin M. Esposito, Alex J. Klein, Shivani Ghoshal, Sachin Agarwal, et al.

    Background: The Functional Outcome in Patients with Primary Intracerebral Hemorrhage (FUNC) score was initially validated for prediction of functional independence on the Glasgow Outcome Scale (GOS) 90 days after intracerebral hemorrhage (ICH), but recovery often extends beyond three months. Aims: Our objective was to extend the FUNC score for prediction of 12-month functional independence to strengthen its utility for family counseling and research methodology. Methods: We conducted a single-center prospective cohort study enrolling adult patients with primary ICH between February 2009 and January 2018. We calculated FUNC scores at admission and assessed GOS 12 months after ICH. The primary outcome was 12-month functional independence, defined as a GOS score ≥4. We calculated the area under the receiver operating characteristic curve (AUC) of the FUNC score using logistic regression, handling missing GOS with multiple imputation by chained equations. We evaluated score calibration using a calibration curve and the Brier score, and we assessed clinical utility using decision curve analysis. We explored the statistical efficiency gains of using FUNC-based sliding dichotomy thresholds for favorable outcome definitions by running simulations of a clinical trial with 1:1 randomization. We ran 5000 simulations for each sample size (100 to 1000, in increments of 10) and treatment effect (odds ratio of 1.5, 2.0 and 2.5) combination and calculated efficiency gains for each respective treatment effect as the percentage reduction in sample size required to have 80% power using sliding versus fixed dichotomy thresholds. Results: A total of 535 patients were included (median [IQR] age 68 [54-79], 237 [44%] female, median [IQR] NIHSS 16 [6-25], median [IQR] FUNC 8 [6-9]). Overall, 99 of 445 (22%) patients with known 12-month GOS achieved functional independence. The FUNC score had an AUC of 0.79 (95%-CI: 0.75-0.84) for 12-month functional independence. The calibration plot was reasonable, with modest evidence of overestimation at low predicted probabilities, and the Brier score was 0.15. A net benefit was observed across 5-50% threshold probabilities. Sliding dichotomy had an efficiency gain of 27% for a treatment effect of OR=2.0, and a gain of 22% for a treatment effect of OR=2.5. The efficiency gain for a treatment effect of OR=1.5 could not be calculated because the fixed dichotomy did not reach 80% power despite a sample size of 1000 patients. Conclusions: The FUNC score’s predictive performance for 12-month functional independence was comparable to its originally validated 3-month discrimination. Following external validation across centers, the FUNC score may be leveraged to counsel families on global measures of long-term functional independence and to implement sliding dichotomy methodology in ICH research.

  • Open Access

    Prevalence, semiology and neuroimaging of movements in comatose adults at risk of death by neurologic criteria: a prospective cohort study

    by Joel Neves Briard, Shane W. English, Dean A. Fergusson, Sonny Dhanani, François Lauzier, Alexis F. Turgeon, Ian Ball, Sultan Darvesh, Polina Titova, Martine Lebrasseur, et al.

    In comatose patients at risk of death by neurologic criteria (DNC), spinal-mediated movements (SMM) and movements of unclear neuroanatomic origin (MUO) are


  • Open Access

    Surface EEG to identify cognitive motor dissociation after acute brain injury

    by Satoshi Egawa, Nicole Casson, Joel Neves Briard, Qi Shen, Vedant Kansara, Itamar Niesvizky-Kogan, Elizabeth Carroll, Jerina C. Carmona, You Lim Song, Alex J. Klein, et al.

    Objective: Cognitive motor dissociation (CMD) is associated with long-term recovery in acute brain injury, but CMD testing is only available in few centers. Our objective was to identify surface EEG patterns with high sensitivity or positive predictive value (PPV) for CMD in patients with acute disorders of consciousness to refine allocation of this resource-intensive test. Methods: In this observational cohort study, we enrolled clinically unresponsive, acutely brain injured patients who underwent continuous surface EEG and CMD assessments. CMD was detected by applying a machine learning algorithm to EEG acquired during a motor command paradigm presentation. Electroencephalographers blinded to CMD test results applied standardized ACNS criteria to the EEGs acquired during CMD assessments. We calculated accuracy measures of surface EEG findings for CMD test results using generalized estimating equations, with an exchangeable matrix and accounting for repeated measures per patient. Results: We included 185 patients (mean age: 62 ± 17; 85 [46%] female) and 282 CMD assessments. CMD testing was positive in 39 (14%) assessments. Sensitivity and PPV of normal background voltage, symmetry and continuity were respectively 77% (95%-CI: 60-88%) and 19% (95%-CI: 13-26%), 74% (95%-CI: 58-86%) and 14% (95%-CI: 10-20%), and 74% (95%-CI: 58-86%) and 14% (95%-CI: 9-19%). All EEGs with burst suppression, suppression, sporadic epileptiform discharges, lateralized periodic discharges, bilateral independent periodic discharges, electrographic seizures and brief potentially ictal rhythmic discharges had negative CMD tests. Interpretation: Surface EEG findings are not reliable to screen for CMD or to identify patterns conferring higher CMD pretest probability.

  • Open Access

    Accuracy of electronic medical records to quantify rates of sedative and analgesic infusions for acute disorders of consciousness big data research

    by Joel Neves Briard, Vedant Kansara, Roxana Dumitru, Qi Shen, Sweta Patel, You Lim Song, Samvrit Vasudev Rao, Alex J Klein, Bert Vancura, Angela Velazquez, et al.

    Background/Objective: The reliability of electronic medical records (EMR) for exposure to sedative and analgesic medications in patients with acute disorders of consciousness is unknown. Our objective was to quantify the accuracy of sedative and analgesic infusion rates derived from the EMR to support its use in big data clinical research. Methods: We conducted a prospective cohort study enrolling critically ill patients who were unresponsive to verbal commands after acute brain injury. During standardized behavioral assessments, research coordinators documented infusing sedative and analgesic medications in case report forms (CRF; reference standard). We extracted infusion rates from the EMR (index) and calculated concordance correlation coefficients for drugs with ≥ 10 EMR-CRF infusion rate pairs. Results: Among 63 included patients (median age: 61 [46-72]; 22 [35%] female), we collected 404 pairs (225 fentanyl, 86 propofol, 70 dexmedetomidine, 19 midazolam, 4 ketamine). Correlation coefficients were 0.82 (95% CI: 0.69-0.91) for propofol, 0.93 (95% CI: 0.85-0.97) for fentanyl, 0.92 (95% CI: 0.81-0.98) for dexmedetomidine and 0.94 (95% CI: 0.55-1.00) for midazolam. Conclusions: EMR derived data on sedative and analgesic infusion rates has variable but overall adequate accuracy to support big data research. External validation is required to support its routine use in clinical research.

  • Open Access

    Door-In-Door-Out Times and Functional Outcomes after Stroke in a Large Canadian Hub-and-Spoke Network

    by Aymen Sahal, Joel Neves Briard, Leila Azzi, Mélanie Lalancette-Hébert, Bastien Rioux, Céline Odier, Catherine Legault, Marie-Christine Camden, François Moreau, Michel Beaudry, et al.

    Background: The determinants of door-in-door-out metrics (DIDO) at centers referring acute ischemic stroke patients for endovascular thrombectomy (EVT) and the impact of DIDO on functional outcomes are unclear. Our primary objective was to study the association between DIDO and 90-day functional outcomes. Our secondary objective was to investigate the associations between patient clinical and workflow characteristics and DIDO. Methods: We conducted a province-wide multicentric retrospective cohort study in Québec, Canada, of adults with acute ischemic stroke who were transferred from a primary stroke center (PSC) to a comprehensive stroke center for EVT between 2017 and 2020. DIDO was calculated as the time spent in the PSC emergency department. Our co-primary outcomes, assessed 90 days after stroke, were a favorable functional outcome (modified Rankin score of 0–2) and death. We estimated associations between DIDO and co-primary outcomes and between patient characteristics and DIDO using logistic mixed models. Results: Among 790 included patients, the mean age was 69 (+/–14) years, and 400 (51%) were female. The median DIDO was 102 (80–135) minutes. DIDO was not associated with 90-day favorable functional outcome (aOR: 1.00, 95% CI [0.99–1.00], p = 0.54) or death (aOR: 1.00, 95% CI [0.99–1.01], p = 0.69). Arrival at the PSC outside daytime hours (aOR: 3.28, 95% CI [1.26–8.51], p = 0.01) was significantly associated with DIDO ≥ 60 minutes. Conclusions: Although DIDO are long in Québec, they are not associated with 90-day functional outcomes or mortality among patients transferred for EVT. Further research is required to develop strategies to improve modifiable determinants of DIDO, including workflow outside of daytime hours.


  • Open Access

    Thoraco-abdominal normothermic regional perfusion does not restore cerebral blood flow or electrical activity despite collateral supra-aortic blood flow in a porcine model

    by Matthieu Glorion, Joel Neves Briard, Louise Roquebert, Sabina Pizzi, Ahmed Menaouar, Mélanie Borie, Manon Robert, Dang Khoa Nguyen, Michaël Chassé, Basil Nasir, et al.


  • Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities

    by Joel Neves Briard, Antoine Duquette, Romain Cayrol, Samuel Lapalme-Remis

    To report a case of fatal super-refractory status epilepticus associated with amyloid-related imaging abnormalities (ARIA). We describe the history, neuroimaging, EEG, and brain pathology findings of a 75-year-old patient with mild cognitive impairment due to Alzheimer disease (homozygous ε4 apolipoprotein status) and a remote history of 3 asymptomatic ARIA episodes, who developed super-refractory status epilepticus related to severe ARIA. The patient was participating in an extended open-label trial of aducanumab when she was admitted to hospital for focal seizures and ARIA in 2 noncontiguous regions of the left frontal and occipital lobes. Despite aggressive treatment with high-dose corticosteroids, sedation, and antiseizure medications, she died from refractory focal status epilepticus. In retrospect, routine surveillance brain magnetic resonance imaging performed 11 weeks before hospitalization had signs of ARIA, which had not been identified. Clinicians should be aware that anti-amyloid therapies may cause rare serious adverse events. A high degree of vigilance is required in the interpretation of surveillance imaging for ARIA. Longitudinal studies are justified to further characterize the safety profile of anti-amyloid antibody therapies and identify participants at high risk of serious adverse events.


  • A Prospective Post-Marketing Observational Study of Brivaracetam in People With Focal Epilepsy

    by Rayan Yanes, Joel Neves Briard, Tang-Duc Jeremy Nguyen, Maya Sultanem, Dang Khoa Nguyen, Steve Gibbs, Kristin Ikeda, Jeffrey Jirsch, Colin Josephson, Lysa Boisse Lomax, et al.

    We evaluated the effectiveness and tolerability of brivaracetam (BRV), an adjunctive antiseizure medication, as a treatment for focal epilepsy in adults. In this prospective study, we enrolled 51 participants from 3 sites across Canada. At 6 months, 68% (26/38) of participants were still taking BRV, among whom 35% (8/23) attained seizure freedom and 48% (11/23) saw their seizure frequency reduced by over 50%. We did not measure any significant change in irritability, quality of life, depression, and anxiety while treated with BRV. Our findings suggest BRV is effective in reducing seizure frequency among adults with focal epilepsy.